News | July 01, 2007

Study Validates Savings Generated by MedSolutions’ Radiology Management Programs

July 2, 2007 - Believed to be the first study to demonstrate cost savings for radiology management with statistical analyses, a report by a Milliman team recently released by MedSolutions Inc. shows per member per month (PMPM) savings for a program that managed three high technology diagnostic imaging services covered by the MedSolutions: contract-computerized axial tomography (CAT), magnetic resonance imaging (MRI) and positron emission tomography (PET).

“The reductions compared to trend generated for the HMO after MedSolutions’ involvement are impressive, especially in light of double-digit inflation for high-tech imaging studies,” says Kathryn Fitch, RN, MEd and principal at Milliman. “We estimate that, compared to costs based on historical trends, the HMO’s allowed PMPM experience was lower during the MedSolutions management period by 30 percent during 2Q05-4Q05 and 42 percent during 1Q06-3Q06.”

Industry experts attribute about 10 percent of the total commercial medical spend to radiology, and the growth in volume has been significant. According to the Blue Cross Blue Shield Association (2006), over the course of three years (1999 to 2001) the number of MRI scans rose by more than 45 percent. Diagnostic imaging services paid under the Medicare Physician fee schedule grew more rapidly than any other physician category between 1999 and 2003, at 45 percent more than twice the growth for all physician services. The primary drivers of trends in imaging costs include increased inappropriate and redundant use of imaging, increased sales and installation of imaging scanners, development of new high-tech imaging and direct marketing to consumers.

For more information: www.medsolutions.com, www.milliman.com

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...